Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 2734976, 16 pages
https://doi.org/10.1155/2017/2734976
Research Article

Cytotoxicity, Oxidative Stress, Cell Cycle Arrest, and Mitochondrial Apoptosis after Combined Treatment of Hepatocarcinoma Cells with Maleic Anhydride Derivatives and Quercetin

1Departamento de Bioquímica y Sección de Graduados, Escuela Superior de Medicina del IPN, Ciudad de México, Mexico
2CONACYT, Facultad de Medicina y Cirugía, Universidad Autónoma Benito Juárez de Oaxaca, Oaxaca de Juárez, OAX, Mexico
3Departamento de Biología Celular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México, Mexico

Correspondence should be addressed to José Guadalupe Trujillo-Ferrara; xm.npi@ollijurtj and Verónica Rocío Vásquez-Garzón; xm.tycanoc@agzeuqsavrv

Received 22 February 2017; Revised 12 June 2017; Accepted 18 July 2017; Published 10 October 2017

Academic Editor: Christian Widmann

Copyright © 2017 Gabriela Carrasco-Torres et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Hay, “Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?” Nature Reviews Cancer, vol. 16, no. 10, pp. 635–649, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. D. Bhutia, E. Babu, S. Ramachandran, and V. Ganapathy, “Amino acid transporters in cancer and their relevance to “glutamine addiction”: novel targets for the design of a new class of anticancer drugs,” Cancer Research, vol. 75, no. 9, pp. 1782–1788, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. O. Warburg, “On the origin of cancer cells,” Science, vol. 123, no. 3191, pp. 309–314, 1956. View at Publisher · View at Google Scholar
  4. S. Perez, R. Taléns-Visconti, S. Rius-Pérez, I. Finamor, and J. Sastre, “Redox signaling in the gastrointestinal tract,” Free Radical Biology and Medicine, vol. 104, pp. 75–103, 2017. View at Publisher · View at Google Scholar
  5. C. V. Recktenwald, R. Kellner, R. Lichtenfels, and B. Seliger, “Altered detoxification status and increased resistance to oxidative stress by K-ras transformation,” Cancer Research, vol. 68, no. 24, pp. 10086–10093, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Benassi, M. Fanciulli, F. Fiorentino et al., “C-Myc phosphorylation is required for cellular response to oxidative stress,” Molecular Cell, vol. 21, no. 4, pp. 509–519, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J. L. Roh, E. H. Kim, H. Jang, and D. Shin, “Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis,” Redox Biology, vol. 11, pp. 254–262, 2016. View at Publisher · View at Google Scholar
  8. H. Pelicano, L. Feng, Y. Zhou et al., “Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism,” The Journal of Biological Chemistry, vol. 278, no. 39, pp. 37832–37839, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. J. R. Kirshner, V. Balasubramanyam, J. Kepros et al., “Elesclomol induces cancer cell apoptosis through oxidative stress,” Molecular Cancer Therapeutics, vol. 7, no. 8, pp. 2319–2327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Chen, J. Zhou, and C. Ji, “Quercetin: a potential drug to reverse multidrug resistance,” Life Sciences, vol. 87, no. 11-12, pp. 333–338, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Niedzwiecki, M. W. Roomi, T. Kalinovsky, and M. Rath, “Anticancer efficacy of polyphenols and their combinations,” Nutrients, vol. 8, no. 9, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. J. A. Choi, J. Y. Kim, J. Y. Lee et al., “Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin,” International Journal of Oncology, vol. 19, no. 4, pp. 837–844, 2001. View at Publisher · View at Google Scholar
  13. L. Yang, Y. Liu, M. Wang et al., “Quercetin-induced apoptosis of HT-29 colon cancer cells via inhibition of the Akt-CSN6-Myc signaling axis,” Molecular Medicine Reports, vol. 14, no. 5, pp. 4559–4566, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. A. K. Maurya and M. Vinayak, “Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line,” Molecular Biology Reports, vol. 42, no. 9, pp. 1419–1429, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Bishayee, A. R. Khuda-Bukhsh, and S. O. Huh, “PLGA-loaded gold-nanoparticles precipitated with quercetin downregulate HDAC-Akt activities controlling proliferation and activate p53-ROS crosstalk to induce apoptosis in hepatocarcinoma cells,” Molecules and Cells, vol. 38, no. 6, pp. 518–527, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Plackova, M. Šála, M. Šmídková et al., “9-norbornyl-6-chloropurine (NCP) induces cell death through GSH depletion-associated ER stress and mitochondrial dysfunction,” Free Radical Biology and Medicine, vol. 97, pp. 223–235, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. R. A. Rafiq, A. Quadri, L. A. Nazir, K. Peerzada, B. A. Ganai, and S. A. Tasduq, “A potent inhibitor of phosphoinositide 3-kinase (PI3K) and mitogen activated protein (MAP) kinase signalling, quercetin (3, 3, 4, 5, 7-pentahydroxyflavone) promotes cell death in ultraviolet (UV)-B-irradiated B16F10 melanoma cells,” PLoS One, vol. 10, no. 7, article e0131253, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Andrade-Jorge, M. Godínez-Victoria, L. E. Sánchez-Torres, L. H. Fabila-Castillo, and J. G. Trujillo-Ferrara, “Aryl maleimides as apoptosis inducers on L5178-Y murine leukemia cells (in silico, in vitro and ex vivo study),” Anti-Cancer Agents in Medicinal Chemistry, vol. 16, no. 12, pp. 1615–1621, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Trujillo-Ferrara, R. Santillan, H. I. Beltrán, N. Farfán, and H. Höpfl, “1H and 13C NMR spectra for a series of arylmaleamic acids, arylmaleimides, arylsuccinamic acids and arylsuccinimides,” Magnetic Resonance in Chemistry, vol. 37, no. 9, pp. 682–686, 1999. View at Google Scholar
  20. N. S. Chandel, P. T. Schumacker, and R. H. Arch, “Reactive oxygen species are downstream products of TRAF-mediated signal transduction,” The Journal of Biological Chemistry, vol. 276, no. 46, pp. 42728–42736, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, vol. 136, no. 5, pp. E359–E386, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. H. B. El-Serag and K. L. Rudolph, “Hepatocellular carcinoma: epidemiology and molecular carcinogenesis,” Gastroenterology, vol. 132, no. 7, pp. 2557–2576, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Y. Liao, C. C. Lee, C. C. Tsai et al., “Novel investigations of flavonoids as chemopreventive agents for hepatocellular carcinoma,” BioMed Research International, vol. 2015, Article ID 840542, 26 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. J. H. Jeong, J. Y. An, Y. T. Kwon, J. G. Rhee, and Y. J. Lee, “Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression,” Journal of Cellular Biochemistry, vol. 106, no. 1, pp. 73–82, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. M. Seufi, S. S. Ibrahim, T. K. Elmaghraby, and E. E. Hafez, “Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences,” Journal of Experimental & Clinical Cancer Research, vol. 28, p. 80, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. F. Brito, M. Ribeiro, A. M. Abrantes et al., “New approach for treatment of primary liver tumors: the role of quercetin,” Nutrition and Cancer, vol. 68, no. 2, pp. 250–266, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Deng, B. Zhang, S. Zhang et al., “Low nanomolar concentrations of cucurbitacin-I induces G2/M phase arrest and apoptosis by perturbing redox homeostasis in gastric cancer cells in vitro and in vivo,” Cell Death and Disease, vol. 7, article e2106, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. F. D. Meng, Y. Li, X. Tian et al., “Synergistic effects of snail and quercetin on renal cell carcinoma Caki-2 by altering AKT/mTOR/ERK1/2 signaling pathways,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 6, pp. 6157–6168, 2015. View at Google Scholar
  29. S. N. Tang, C. Singh, D. Nall, D. Meeker, S. Shankar, and R. K. Srivastava, “The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition,” Journal of Molecular Signaling, vol. 5, p. 14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. S. Kalgutkar, B. C. Crews, and L. J. Marnett, “Design, synthesis, and biochemical evaluation of N-substituted maleimides as inhibitors of prostaglandin endoperoxide synthases,” Journal of Medicinal Chemistry, vol. 39, no. 8, pp. 1692–1703, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. O. Son, K. Y. Lee, S. H. Kook et al., “Selective effects of quercetin on the cell growth and antioxidant defense system in normal versus transformed mouse hepatic cell lines,” European Journal of Pharmacology, vol. 502, no. 3, pp. 195–204, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Yi, Y. Zongyuan, G. Cheng, Z. Lingyun, Y. Guilian, and G. Wei, “Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway,” Cancer Science, vol. 105, no. 5, pp. 520–527, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. T. K. MacLachlan, N. Sang, and A. Giordano, “Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer,” Critical Reviews in Eukaryotic Gene Expression, vol. 5, no. 2, pp. 127–156, 1995. View at Publisher · View at Google Scholar
  34. Z. Yuan, C. Long, T. Junming, L. Qihuan, Z. Youshun, and Z. Chan, “Quercetin-induced apoptosis of HL-60 cells by reducing PI3K/Akt,” Molecular Biology Reports, vol. 39, no. 7, pp. 7785–7793, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. Q. Zhang, X. H. Zhao, and Z. J. Wang, “Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis,” Food and Chemical Toxicology, vol. 46, no. 6, pp. 2042–2053, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Srivastava, R. R. Somasagara, M. Hegde et al., “Quercetin, a natural flavonoid interacts with DNA, Arrests Cell Cycle and Causes Tumor Regression by Activating Mitochondrial Pathway of Apoptosis,” Scientific Reports, vol. 6, article 24049, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Wang, A. Han, E. Chen et al., “The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells,” International Journal of Oncology, vol. 46, no. 5, pp. 1924–1934, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Dajas, “Life or death: neuroprotective and anticancer effects of quercetin,” Journal of Ethnopharmacology, vol. 143, no. 2, pp. 383–396, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Schnelldorfer, S. Gansauge, F. Gansauge, S. Schlosser, H. G. Beger, and A. K. Nussler, “Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells,” Cancer, vol. 89, no. 7, pp. 1440–1447, 2000. View at Publisher · View at Google Scholar
  40. A. W. Boots, N. Kubben, G. R. Haenen, and A. Bast, “Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation,” Biochemical and Biophysical Research Communications, vol. 308, no. 3, pp. 560–565, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Metodiewa, A. K. Jaiswal, N. Cenas, E. Dickancaité, and J. Segura-Aguilar, “Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product,” Free Radical Biology and Medicine, vol. 26, no. 1-2, pp. 107–116, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Al-Khayal, A. Alafeefy, M. A. Vaali-Mohammed et al., “Novel derivative of aminobenzenesulfonamide (3c) induces apoptosis in colorectal cancer cells through ROS generation and inhibits cell migration,” BMC Cancer, vol. 17, no. 1, p. 4, 2017. View at Publisher · View at Google Scholar